Patents by Inventor Kerrie McDonald

Kerrie McDonald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11446283
    Abstract: Methods and dosing regimens for treating glioblastoma or recurrent glioblastoma and its associated symptoms by administration of ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine) or a pharmaceutically acceptable salt thereof and at least one or more other therapeutic agent.
    Type: Grant
    Filed: July 10, 2020
    Date of Patent: September 20, 2022
    Assignee: MediciNova, Inc.
    Inventors: Kazuko Matsuda, Kerrie McDonald
  • Publication number: 20210023063
    Abstract: Methods and dosing regimens for treating glioblastoma or recurrent glioblastoma and its associated symptoms by administration of ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine) or a pharmaceutically acceptable salt thereof and at least one or more other therapeutic agent.
    Type: Application
    Filed: July 10, 2020
    Publication date: January 28, 2021
    Applicant: MediciNova, Inc.
    Inventors: Kazuko Matsuda, Kerrie McDonald
  • Patent number: 10744123
    Abstract: Methods and dosing regimens for treating glioblastoma or recurrent glioblastoma and its associated symptoms by administration of ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine) or a pharmaceutically acceptable salt thereof and at least one or more other therapeutic agent.
    Type: Grant
    Filed: February 11, 2019
    Date of Patent: August 18, 2020
    Assignee: MediciNova, Inc.
    Inventors: Kazuko Matsuda, Kerrie McDonald
  • Publication number: 20200038382
    Abstract: Compositions and methods for treating glioblastoma or recurrent glioblastoma and its associated symptoms by administration of ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 9, 2019
    Publication date: February 6, 2020
    Applicant: MediciNova, Inc.
    Inventors: Kazuko Matsuda, Kerrie McDonald
  • Patent number: 10391085
    Abstract: Compositions and methods for treating glioblastoma or recurrent glioblastoma and its associated symptoms by administration of ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: August 27, 2019
    Assignee: MediciNova, Inc.
    Inventors: Kazuko Matsuda, Kerrie McDonald
  • Publication number: 20190247370
    Abstract: Methods and dosing regimens for treating glioblastoma or recurrent glioblastoma and its associated symptoms by administration of ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine) or a pharmaceutically acceptable salt thereof and at least one or more other therapeutic agent.
    Type: Application
    Filed: February 11, 2019
    Publication date: August 15, 2019
    Applicant: MediciNova, Inc.
    Inventors: Kazuko Matsuda, Kerrie McDonald
  • Publication number: 20180177772
    Abstract: Compositions and methods for treating glioblastoma or recurrent glioblastoma and its associated symptoms by administration of ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 21, 2017
    Publication date: June 28, 2018
    Applicant: MediciNova, Inc.
    Inventors: Kazuko Matsuda, Kerrie McDonald